Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

National Clinical Guideline - Diagnosis and staging of patients with Prostate Cancer


Topic: Prostate cancer
Document Owner: National cancer control programme
National Group: Evidence and quality hub, nccp
Effective From: 07 July 2022
HSE national clinical guideline for the diagnosis and staging of patients with prostate cancer.
National Clinical Guideline - Diagnosis and staging of patients with Prostate Cancer PDF, 0.94MB

This national clinical guideline was developed by a multidisciplinary Guideline Development Group and is based upon the best clinical evidence available together with the clinical expertise of the Group members. The Guideline supersedes all previous Health Service Executive (HSE), National Cancer Control Programme (NCCP) and National Clinical Effectiveness Committee (NCEC) guidelines for radiological diagnosis and staging of patients with prostate cancer.

Back to HSE National Policies, Procedures, Protocols, Guidelines and Clinical Guidelines